Nonpermissive HLA-DPB1 disparity is a significant independent risk factor for mortality after unrelated hematopoietic stem cell transplantation

Blood

Volumn 114, Issue 7, 2009, Pages 1437-1444

  Crocchiolo, Roberto ^a,b   Zino, Elisabetta ^a   Vago, Luca ^a,c   Oneto, Rosi ^d   Bruno, Barbara ^d   Pollichieni, Simona ^e   Sacchi, Nicoletta ^e   Sormani, Maria Pia ^b   Marcon, Jessica ^a,c   Lamparelli, Teresa ^d   Fanin, Renato ^f   Garbarino, Lucia ^d   Miotti, Valeria ^g   Bandini, Giuseppe ^h   Bosi, Alberto ⁱ   Ciceri, Fabio ^a   Bacigalupo, Andrea ^d   Fleischhauer, Katharina ^a,c  

^a SAN RAFFAELE HOSPITAL   (Italy)

^b UNIVERSITY OF GENOA   (Italy)

^c SAN RAFFAELE SCIENTIFIC INSTITUTE   (Italy)

^d UNIVERSITY OF GENOA   (Italy)

^e GALLIERA HOSPITAL   (Italy)

^f UNIVERSITY OF UDINE   (Italy)

^g SANTA MARIA DELLA MISERICORDIA UNIVERSITY HOSPITAL   (Italy)

^h UNIVERSITY OF BOLOGNA   (Italy)

ⁱ UNIVERSITY OF FLORENCE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

HLA DPB1 ANTIGEN; HLA DR ANTIGEN; HLA-DRB1 ANTIGEN;

ADULT; AGED; ALGORITHM; ALLELE; ALLOIMMUNITY; ARTICLE; CONTROLLED STUDY; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; IMMUNOGENICITY; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RISK FACTOR; SURVIVAL RATE; TREATMENT OUTCOME; ALLOTRANSPLANTATION; BLOOD DISEASE; CLINICAL TRIAL; DISEASE FREE SURVIVAL; DONOR; DONOR SELECTION; ITALY; METHODOLOGY; MIDDLE AGED; MULTICENTER STUDY; RECURRENT DISEASE; REGISTER; RETROSPECTIVE STUDY;

ADULT; ALGORITHMS; DISEASE-FREE SURVIVAL; DONOR SELECTION; FEMALE; HEMATOLOGIC NEOPLASMS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HLA-DR ANTIGENS; HUMANS; ITALY; MALE; MIDDLE AGED; RECURRENCE; REGISTRIES; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL RATE; TISSUE DONORS; TRANSPLANTATION, HOMOLOGOUS;

EID: 70349342800     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2009-01-200378     Document Type: Article

References (35)

1. Shaw S, Johnson AH, Shearer GM. Evidence for a new segregant series of B cell antigens that are encoded in the HLA-D region and that stimulate secondary allogenic proliferative and cytotoxic responses. J Exp Med. 1980;152:565-580. (Pubitemid 10059490)
2. Schultz ES, Lethe B, Cambiaso CL, et al. A MAGE-A3 peptide presented by HLA-DP4 is recognized on tumor cells by CD4+ cytolytic T lymphocytes. Cancer Res. 2000;60:6272-6275. (Pubitemid 30952121)
3. Piersma SJ, Welters MJ, van der Hulst JM, et al. Human papilloma virus specific T cells infiltrating cervical cancer and draining lymph nodes show remarkably frequent use of HLA-DQ and -DP as a restriction element. Int J Cancer. 2008;122:486-494.
4. Celis E, Karr RW. Presentation of an immunodominant T-cell epitope of hepatitis B surface antigen by the HLA-DPw4 molecule. J Virol. 1989;63:747-752. (Pubitemid 19057241)
5. Gaschet J, Trevino MA, Cherel M, et al. HLA-target antigens and T-cell receptor diversity of activated T cells invading the skin during acute graft-vs-host disease. Blood. 1996;87:2345-2353. (Pubitemid 26086876)
6. Gaschet J, Lim A, Liem L, et al. Acute graft vs host disease due to T lymphocytes recognizing a single HLA-DPB1*0501 mismatch. J Clin Invest. 1996;98:100-107. (Pubitemid 26243825)
7. Tambur AR, Buckingham M, McDonald L, Luo X. Development of donor-specific and non-donor-specific HLA-DP antibodies post-transplant: the role of epitope sharing and epitope matching. Clin Transpl. 2006:399-404.
8. Mitsunaga S, Kuwata S, Tokunaga K, et al. Family study on HLA-DPB1 polymorphism: linkage analysis with HLA-DR/DQ and two "new" alleles. Hum Immunol. 1992;34:203-211.
9. Ludajic K, Balavarca Y, Bickeboller H, et al. Impact of HLA-DPB1 allelic and single amino acid mismatches on HSCT. Br J Haematol. 2008;142:436-443. (Pubitemid 351965482)
10. Loiseau P, Busson M, Balere ML, et al. HLA association with hematopoietic stem cell transplantation outcome: the number of mismatches at HLA-A, -B, -C, -DRB1, or -DQB1 is strongly associated with overall survival. Biol Blood Marrow Transplant. 2007;13:965-974. (Pubitemid 47055388)
11. Zino E, Frumento G, Marktel S, et al. A T-cell epitope encoded by a subset of HLA-DPB1 alleles determines nonpermissive mismatches for hematologic stem cell transplantation. Blood. 2004;103:1417-1424. (Pubitemid 38168657)
12. Diaz G, Catalfamo M, Coiras MT, et al. HLA-DP-beta residue 69 plays a crucial role in allorecognition. Tissue Antigens. 1998;52:27-36. (Pubitemid 28327722)
13. Cesbron A, Moreau P, Milpied N, Harousseau JL, Muller JY, Bignon JD. Crucial role of the third and fourth hypervariable regions of HLA-DPB1 allelic sequences in the mixed lymphocyte reaction. Hum Immunol. 1992;33:202-207.
14. Nicholson I, Varney M, Kanaan C, et al. Alloresponses to HLA-DP detected in the primary MLR: correlation with a single amino acid difference. Hum Immunol. 1997;55:163-169. (Pubitemid 27467988)
15. Dini G, Cancedda R, Locatelli F, et al. Unrelated donor marrow transplantation: an update of the experience of the Italian Bone Marrow Group (GITMO). Haematologica. 2001;86:451-456. (Pubitemid 33638971)
16. Glucksberg H, Storb R, Fefer A, et al. Clinical manifestations of graft-vs-host disease in human recipients of marrow from HL-A-matched sibling donors. Transplantation. 1974;18:295-304.
17. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc. 1958;53:457-481.
18. Mantel N. Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep. 1966;50:163-170.
19. Cox DR. Regression models and life-tables. J R Stat Soc Ser B-Stat Methodol. 1972;34:187-220.
20. Zino E, Vago L, Di Terlizzi S, et al. Frequency and targeted detection of HLA-DPB1 T cell epitope disparities relevant in unrelated hematopoietic stem cell transplantation. Biol Blood Marrow Transplant. 2007;13:1031-1040. (Pubitemid 47215559)
21. Rutten CE, van Luxemburg-Heijs SA, Griffioen M, et al. HLA-DP as specific target for cellular immunotherapy in HLA class II-expressing B-cell leukemia. Leukemia. 2008;22:1387-1394. (Pubitemid 352006083)
22. Fleischhauer K, Locatelli F, Zecca M, et al. Graft rejection after unrelated donor hematopoietic stem cell transplantation for thalassemia is associated with nonpermissive HLA-DPB1 disparity in host-vs-graft direction. Blood. 2006;107:2984-2992.
23. Fleischhauer K, Zino E, Mazzi B, et al. Peripheral blood stem cell allograft rejection mediated by CD4(+) T lymphocytes recognizing a single mismatch at HLA-DP beta 1*0901. Blood. 2001;98:1122-1126.
24. Shaw BE, Gooley TA, Malkki M, et al. The importance of HLA-DPB1 in unrelated donor hematopoietic cell transplantation. Blood. 2007;110:4560-4566.
25. Shaw BE, Marsh SG, Mayor NP, Russell NH, Madrigal JA. HLA-DPB1 matching status has significant implications for recipients of unrelated donor stem cell transplants. Blood. 2006;107:1220-1226.
26. Flomenberg N, Baxter-Lowe LA, Confer D, et al. Impact of HLA class I and class II high-resolution matching on outcomes of unrelated donor bone marrow transplantation: HLA-C mismatching is associated with a strong adverse effect on transplantation outcome. Blood. 2004;104:1923-1930. (Pubitemid 39297840)
27. Lee SJ, Klein J, Haagenson M, et al. High-resolution donor-recipient HLA matching contributes to the success of unrelated donor marrow transplantation. Blood. 2007;110:4576-4583.
28. Spellman S, Setterholm M, Maiers M, et al. Advances in the selection of HLA-compatible donors: refinements in HLA typing and matching over the first 20 years of the National Marrow Donor Program Registry. Biol Blood Marrow Transplant. 2008;14:37-44.
29. Hurley CK, Wagner JE, Setterholm MI, Confer DL. Advances in HLA: practical implications for selecting adult donors and cord blood units. Biol Blood Marrow Transplant. 2006;12:28-33.
30. Hurley CK, Baxter Lowe LA, Logan B, et al. National Marrow Donor Program HLA-matching guidelines for unrelated marrow transplants. Biol Blood Marrow Transplant. 2003;9:610-615. (Pubitemid 38351780)
31. Hurley CK, Baxter-Lowe LA, Begovich AB, et al. The extent of HLA class II allele level disparity in unrelated bone marrow transplantation: analysis of 1259 National Marrow Donor Program donor-recipient pairs. Bone Marrow Transplant. 2000;25:385-393.
32. Begovich AB, Moonsamy PV, Mack SJ, et al. Genetic variability and linkage disequilibrium within the HLA-DP region: analysis of 15 different populations. Tissue Antigens. 2001;57:424-439.
33. Bugawan TL, Klitz W, Blair A, Erlich HA. High-resolution HLA class I typing in the CEPH families: analysis of linkage disequilibrium among HLA loci. Tissue Antigens. 2000;56:392-404.
34. Kawase T, Morishima Y, Matsuo K, et al. High-risk HLA allele mismatch combinations responsible for severe acute graft-vs-host disease and implication for its molecular mechanism. Blood. 2007;110:2235-2241. (Pubitemid 47523140)
35. Duquesnoy RJ, Askar M. HLAMatchmaker: a molecularly based algorithm for histocompatibility determination. V. Eplet matching for HLA-DR, HLA-DQ, and HLA-DP. Hum Immunol. 2007;68:12-25. (Pubitemid 46026884)